| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 1,163,000 | 1,251,000 | 1,142,000 | 1,217,000 | | Cost of Revenue | (907,000) | 447,000 | 731,000 | 1,024,000 | | | Gross Profit | 2,070,000 | 804,000 | 411,000 | 193,000 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 1,811,000 | 525,000 | 161,000 | (89,000) | | Non Recurring | 1,246,000 | 441,000 | 23,000 | 1,684,000 | | Others | 66,000 | 66,000 | 68,000 | 72,000 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 189,000 | (228,000) | 159,000 | (1,474,000) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 11,000 | 9,000 | 9,000 | 21,000 | | Earnings Before Interest And Taxes | 200,000 | (219,000) | 168,000 | (1,453,000) | | Interest Expense | 29,000 | 32,000 | 30,000 | 36,000 | | Income Before Tax | 171,000 | (251,000) | 138,000 | (1,489,000) | | Income Tax Expense | 47,000 | (72,000) | 32,000 | (149,000) | | Minority Interest | 1,000 | (5,000) |
-
|
-
| | | | Net Income From Continuing Ops | 129,000 | (184,000) | 106,000 | (1,340,000) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
| 2,000 | | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 125,000 | (184,000) | 106,000 | (1,338,000) | | Preferred Stock And Other Adjustments |
-
| 2,000 | (2,000) |
-
| | | Net Income Applicable To Common Shares | $125,000 | ($182,000) | $104,000 | ($1,338,000) |
|
0.11% Nasdaq 
0.01%
Income Statement
